SMTL ID : 5xi7.1

Crystal structure of T2R-TTL bound with PO-7

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.99 Å

Oligo State

hetero-2-2-1-1-mer

Ligands

3 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)

GTP.1: 24 residues within 4Å: Chain A: G.10, Q.11, A.12, Q.15, D.69, D.98, A.99, A.100, N.101, S.140, G.143, G.144, T.145, G.146, I.171, V.177, S.178, E.183, N.206, Y.224, N.228, I.231 Chain B: K.252 Ligands: MG.2 31 PLIP interactions: 26 interactions with chain A, 5 interactions with chain B Hydrogen bonds: A:Q.11, A:Q.11, A:A.12, A:Q.15, A:D.98, A:A.99, A:N.101, A:S.140, A:G.143, A:G.144, A:T.145, A:T.145, A:G.146, A:V.177, A:E.183, A:N.206, A:N.206, A:Y.224, A:N.228, A:N.228 Water bridges: A:D.98, A:S.140, A:F.141, A:A.174, B:K.252, B:K.252, B:K.252 pi-Stacking: A:Y.224, A:Y.224 Salt bridges: B:K.252, B:K.252 GTP.10: 26 residues within 4Å: Chain C: G.10, Q.11, A.12, Q.15, I.16, D.69, D.98, A.99, A.100, N.101, S.140, G.142, G.143, G.144, T.145, G.146, I.171, V.177, S.178, E.183, N.206, Y.224, N.228, I.231 Chain D: K.252 Ligands: MG.11 29 PLIP interactions: 25 interactions with chain C, 4 interactions with chain D Hydrogen bonds: C:Q.11, C:Q.11, C:A.12, C:Q.15, C:D.69, C:A.99, C:A.100, C:N.101, C:S.140, C:G.144, C:T.145, C:T.145, C:G.146, C:V.177, C:E.183, C:N.206, C:N.206, C:Y.224, C:N.228, C:N.228 Water bridges: C:G.13, C:D.98, C:F.141, D:K.252, D:K.252 pi-Stacking: C:Y.224, C:Y.224 Salt bridges: D:K.252, D:K.252 GTP.13: 21 residues within 4Å: Chain D: G.10, Q.11, C.12, Q.15, I.16, A.97, G.98, N.99, S.138, G.140, G.141, G.142, T.143, G.144, V.175, S.176, E.181, N.204, Y.222, N.226 Ligands: MG.14 20 PLIP interactions: 20 interactions with chain D Hydrogen bonds: D:Q.11, D:Q.11, D:C.12, D:G.98, D:N.99, D:S.138, D:G.142, D:T.143, D:T.143, D:G.144, D:S.145, D:S.176, D:E.181, D:N.204, D:N.204, D:Y.222, D:Y.222, D:N.226, D:N.226 pi-Stacking: D:Y.222

4 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: D.69 Chain B: K.252 Ligands: GTP.1 No protein-ligand interaction detected (PLIP) MG.5: 3 residues within 4Å: Chain B: Q.11, D.177 Ligands: GDP.4 No protein-ligand interaction detected (PLIP) MG.11: 2 residues within 4Å: Chain D: K.252 Ligands: GTP.10 No protein-ligand interaction detected (PLIP) MG.14: 3 residues within 4Å: Chain D: D.67, E.69 Ligands: GTP.13 No protein-ligand interaction detected (PLIP)

3 x CA: CALCIUM ION(Non-covalent)

CA.3: 5 residues within 4Å: Chain A: D.39, T.41, G.44, G.45, E.55 5 PLIP interactions: 5 interactions with chain A Metal complexes: A:D.39, A:T.41, A:T.41, A:G.44, A:E.55 CA.7: 1 residues within 4Å: Chain B: E.111 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:E.111 CA.12: 6 residues within 4Å: Chain C: D.39, T.41, G.44, G.45, D.47, E.55 5 PLIP interactions: 5 interactions with chain C Metal complexes: C:D.39, C:D.39, C:T.41, C:G.44, C:E.55

1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)

GDP.4: 18 residues within 4Å: Chain B: G.10, Q.11, C.12, Q.15, S.138, G.141, G.142, T.143, G.144, V.169, P.171, V.175, D.177, E.181, N.204, Y.222, N.226 Ligands: MG.5 23 PLIP interactions: 23 interactions with chain B Hydrogen bonds: B:Q.11, B:Q.11, B:C.12, B:S.138, B:G.142, B:T.143, B:T.143, B:T.143, B:G.144, B:V.175, B:E.181, B:N.204, B:N.204, B:Y.222, B:N.226, B:N.226 Water bridges: B:S.138, B:G.140, B:G.141, B:S.145, B:D.177 pi-Stacking: B:Y.222, B:Y.222

2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)

MES.6: 9 residues within 4Å: Chain B: R.156, P.160, D.161, R.162, I.163, M.164, N.195, D.197, R.251 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:P.160 Salt bridges: B:D.197, B:R.251 MES.8: 7 residues within 4Å: Chain B: F.294, D.295, S.296, P.305, R.306, Y.310, N.337 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:S.296 Salt bridges: B:R.306

2 x PO7: (6Z)-3-[[2,5-bis(fluoranyl)phenyl]methylidene]-6-[(4-tert-butyl-1H-imidazol-5-yl)methylidene]piperazine-2,5-dione(Non-covalent)

PO7.9: 19 residues within 4Å: Chain A: T.179 Chain B: Y.50, Q.134, N.165, E.198, Y.200, V.236, T.237, C.239, L.240, L.250, L.253, M.257, A.314, A.315, I.316, T.351, A.352, I.368 8 PLIP interactions: 7 interactions with chain B, 1 interactions with chain A Hydrophobic interactions: B:T.237, B:L.250, B:L.250, B:A.314, B:I.316, B:A.352, A:T.179 Hydrogen bonds: B:V.236 PO7.15: 21 residues within 4Å: Chain C: T.179 Chain D: Y.50, Q.134, N.165, F.167, E.198, Y.200, V.236, T.237, C.239, L.240, L.246, L.250, L.253, M.257, A.314, A.315, I.316, K.350, A.352, I.368 10 PLIP interactions: 9 interactions with chain D, 1 interactions with chain C Hydrophobic interactions: D:F.167, D:Y.200, D:T.237, D:L.246, D:L.250, D:L.250, D:A.352, D:I.368, C:T.179 Hydrogen bonds: D:V.236

1 x ACP: PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER(Non-covalent)

ACP.16: 18 residues within 4Å: Chain F: K.74, I.148, K.150, Q.183, K.184, Y.185, L.186, K.198, D.200, R.202, R.222, T.241, N.242, D.318, M.320, I.330, E.331, N.333 15 PLIP interactions: 15 interactions with chain F Hydrogen bonds: F:K.74, F:K.150, F:Q.183, F:L.186, F:K.198, F:R.202, F:R.222, F:R.222, F:T.241, F:T.241, F:N.242, F:N.333 Salt bridges: F:K.74, F:K.150 pi-Stacking: F:Y.185

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chu, Y. et al., Synthesis, biological evaluation and X-ray structure of anti-microtubule agents. To Be Published

Release Date

2017-10-18

Peptides

Tubulin alpha chain: AC
Tubulin beta chain: BD
Stathmin-4: E
Tubulin tyrosine ligase: F

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

B
B

D
D

E
E

F
F

Tubulin alpha chain

Tubulin beta chain

Stathmin-4

Tubulin tyrosine ligase

Related Entries With Identical Sequence